Resources
4 Results (showing 1 - 4)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 11/7/2023 (updated 3/28/2024)
Grantees from the Implementation III & IV, Behavioral Health Support, Psychostimulant Support I & II cohorts are invited to this “re-welcome” webinar to kick-off the new project year.
Posted 10/23/2023 (updated 3/27/2024)
The Reagan-Udall Foundation partnered with the Food and Drug Administration (FDA) for the "Mitigating Risks from Human Xylazine Exposure" virtual and in-person webinar that occurred early October 2023. This public meeting explored real-world experiences and scientific evidence on emerging data trends for human xylazine exposure and examined concrete strategies for drug development and clinical research that directly supports the mitigation and reduction of risks associated with human exposure to xylazine. The meeting materials, recordings, and slides are now available for viewing.
Posted 11/23/2022 (updated 3/27/2024)
This webinar provided RCORP grantees with the tools to complete a disparities impact statement, to support efforts to address populations in rural communities that have historically suffered from poorer health outcomes and health inequities as a part of the prevention, treatment, and recovery of SUD/OUD.
Posted 12/8/2021 (updated 3/27/2024)
This webinar provided RCORP Psychostimulant Support program grantees with the tools to complete a behavioral health disparities impact statement, to support efforts to address populations in rural communities that have historically suffered from poorer health outcomes and health inequities as a part of the prevention, treatment and recovery of psychostimulants.